» Authors » Katarzyna Blaszczyk

Katarzyna Blaszczyk

Explore the profile of Katarzyna Blaszczyk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 1108
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ziojla N, Socha M, Guerra M, Kizewska D, Blaszczyk K, Urbaniak E, et al.
Nat Commun . 2025 Feb; 16(1):1999. PMID: 40011454
Stem cells maintain a dynamic dialog with their niche, integrating biochemical and biophysical cues to modulate cellular behavior. Yet, the transcriptional networks that regulate cellular biophysical properties remain poorly defined....
2.
Blaszczyk K, Jedrzejak A, Ziojla N, Shcheglova E, Szarafin K, Jankowski A, et al.
Exp Mol Med . 2024 Dec; 57(1):131-150. PMID: 39741186
Human pluripotent stem cell-derived β-cells (SC-β-cells) represent an alternative cell source for transplantation in diabetic patients. Although mitogens could in theory be used to expand β-cells, adult β-cells very rarely...
3.
Nowicka H, Sekrecka A, Blaszczyk K, Kluzek K, Chang C, Wesoly J, et al.
Int J Mol Sci . 2023 Dec; 24(24). PMID: 38139463
In addition to the canonical ISGF3 and non-canonical STAT2/IRF9 complexes, evidence is emerging of the role of their unphosphorylated counterparts in IFN-dependent and -independent ISG transcription. To better understand the...
4.
Szlachcic W, Dabrowska A, Milewska A, Ziojla N, Blaszczyk K, Barreto-Duran E, et al.
iScience . 2022 Jun; 25(7):104594. PMID: 35756892
Recent studies showed that SARS-CoV-2 can infect adult human pancreas and trigger pancreatic damage. Here, using human fetal pancreas samples and 3D differentiation of human pluripotent cells into pancreatic endocrine...
5.
Shcheglova E, Blaszczyk K, Borowiak M
Front Cell Dev Biol . 2022 Feb; 9:734597. PMID: 35155441
Decreased number and function of beta cells are a key aspect of diabetes mellitus (diabetes), a disease that remains an onerous global health problem. Means of restoring beta cell mass...
6.
Wielogorska E, Blaszczyk K, Chevallier O, Connolly L
Toxicol In Vitro . 2019 Jan; 56:101-109. PMID: 30641124
Global market of herbs has been struggling with food adulteration issues. A number of assays have been developed to aid the detection of the tampered samples and ensure high quality...
7.
Blaszczyk K, Gajewska M, Wilczak J, Kamola D, Majewska A, Harasym J, et al.
Eur J Nutr . 2018 Oct; 58(7):2859-2873. PMID: 30284595
Purpose: Beta-glucans are biologically active polysaccharides having antioxidant, immunomodulatory, and antiinflammatory properties. This study investigated the transcriptomic profile in peripheral blood of rats with LPS-induced enteritis, which were fed a...
8.
Michalska A, Blaszczyk K, Wesoly J, Bluyssen H
Front Immunol . 2018 Jun; 9:1135. PMID: 29892288
Interferon (IFN)-I and IFN-II both induce IFN-stimulated gene (ISG) expression through Janus kinase (JAK)-dependent phosphorylation of signal transducer and activator of transcription (STAT) 1 and STAT2. STAT1 homodimers, known as...
9.
Blaszczyk K, Nowicka H, Kostyrko K, Antonczyk A, Wesoly J, Bluyssen H
Cytokine Growth Factor Rev . 2016 Apr; 29:71-81. PMID: 27053489
In the canonical pathway of IFN-I-mediated signaling, phosphorylation of STAT1 and STAT2 leads to heterodimerization and interaction with IRF9. This complex, also known as IFN-stimulated gene factor 3 (ISGF3), then...
10.
Blaszczyk K, Olejnik A, Nowicka H, Ozgyin L, Chen Y, Chmielewski S, et al.
Biochem J . 2015 Jan; 466(3):511-24. PMID: 25564224
Evidence is accumulating for the existence of a signal transducer and activator of transcription 2 (STAT2)/interferon regulatory factor 9 (IRF9)-dependent, STAT1-independent interferon alpha (IFNα) signalling pathway. However, no detailed insight...